To
investigate the specific functions of conjugated fatty acids
(CFAs) produced by the probiotic bacterium, α-linolenic acid
was isomerized by Lactobacillus plantarum ZS2058, and two different conjugated linolenic acid (CLNA) isomers
were successfully isolated: c9, t11, c15-CLNA (CLNA1) and t9, t11,
c15-CLNA (CLNA2). The effects and mechanism of CLNA crude extract
and individual isomers on colitis were explored. CLNA significantly
inhibited weight loss, the disease activity index, and colon shortening.
Additionally, CLNA alleviated histological damage, protected colonic
mucus layer integrity, and significantly upregulated the concentration
of tight junction proteins (ZO-1, occludin, E-cadherin 1, and claudin-3).
CLNA significantly attenuated the level of proinflammatory cytokines
(TNF-α, IL-1β, and IL-6) while upregulating the expression
of the colonic anti-inflammatory cytokine IL-10 and nuclear receptor
peroxisome-activated receptor-γ. Moreover, CLNA increased the
activity of oxidative stress-related enzymes (SOD, GSH, and CAT),
and the myeloperoxidase activity was significantly decreased by CLNA.
Meanwhile, the concentrations of CLNA in the liver and conjugated
linoleic acid in the colonic content were significantly increased
because of the treatment of CLNA. Furthermore, CLNA could rebalance
the intestinal microbial composition of colitis mice, including increasing
the α-diversity. CLNA1 and CLNA2 increased the abundance of Ruminococcus and Prevotella, respectively.